Arthur Allignol is currently a HTA and medical affairs statistician at Daiichi Sankyo and is actively involved in the PSI/EFSPI HTA Special Interest Group. Before joining Daiichi Sankyo, he worked as Real-World Data Scientist at Merck Healthcare KGaA and in academia, specializing in observational studies and complex event-history analysis. Arthur Allignol obtained his PhD in biostatistics at the university of Freiburg in 2013.